USA approves Johnson & Johnson vaccine emergency use
The US Food and Drug Administration, FDA, approved the single-dose vaccine developed by the Johnson & Johnson company for the new type of coronavirus (Kovid-19).
Thus, Johnson & Johnson’s vaccine became the third coronavirus vaccine to be green-lighted in the country.
FDA Acting Commissioner Dr. “Approving this vaccine will help us in the fight against this epidemic that has claimed the lives of more than half a million people in the US,” said Janet Woodcock.
read more: Global markets await Fed Chairman Powell’s presentation
US President Joe Biden welcomed his approval for the use of the Johnson & Johnson vaccine, but stressed that vigilance should continue.
“This is exciting news for all Americans and an encouraging development in our efforts to end the crisis,” said Biden. “There is light at the end of the tunnel, but now we cannot give up caution or accept victory as inevitable,” he said.
Unlike other vaccines, only one dose of vaccine is expected in the world.
Johnson & Johnson vaccine also has an advantage in the logistics area, as it can be stored in refrigerator cold, which greatly facilitates its distribution.
The US government has announced that at least three million doses of the Johnson & Johnson vaccine are ready for distribution as of next week.
Johnson & Johnson company also pledged to deliver 100 million doses to the US before the end of June.
The US will have enough vaccines to vaccinate almost the entire population by the end of July, with orders of 600 million doses from Pfizer and Moderna.
